4.6 Review

Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Radiotherapy of cervical cancer

C. Chargari et al.

Summary: External beam radiotherapy and brachytherapy are commonly used treatments for cervical cancer. The choice of preoperative or postoperative brachytherapy or chemoradiation depends on the tumor stage, with brachytherapy boost being performed when necessary.

CANCER RADIOTHERAPIE (2022)

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Article Oncology

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

Maud le Guyader et al.

Summary: The study reported the results of using different HDR-BT fractionation schemes for treating LACC, showing similar treatment outcomes for all schemes within five years, but higher-dose schemes resulted in slightly more toxicities. EQD2(10)D(90)CTV(HR) < 85 Gy was identified as a prognostic factor for local recurrence.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)

Review Immunology

Advances in management of locally advanced cervical cancer

Hima Musunuru et al.

Summary: Cervical cancer ranks fourth in terms of incidence and mortality in women globally, but it has effective prevention, screening, and treatment options. Current research focuses on advancements in locally advanced cervical cancer, especially in the field of radiation therapy, with significant progress and future research directions highlighted.

INDIAN JOURNAL OF MEDICAL RESEARCH (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Optimization in treatment planning of high dose-rate brachytherapy - Review and analysis of mathematical models

Bjorn Moren et al.

Summary: Inverse planning is increasingly used in high dose-rate brachytherapy treatment planning, with various proposed optimization models. The mathematical optimization is utilized for decisions on catheter placement and dwell time distributions. The survey aims to give an overview of these models and provide comparisons, as well as suggest future research directions for clinical validation of optimization approaches.

MEDICAL PHYSICS (2021)

Review Oncology

Effects of 3D image-guided brachytherapy compared to 2D conventional brachytherapy on clinical outcomes in patients with cervical cancer: A systematic review and meta-analyses

Erica Aranha Suzumura et al.

Summary: The study suggests that three-dimensional image-guided brachytherapy (3D BT) may have better clinical outcomes compared to bi-dimensional BT (2D BT) in patients with cervical cancer. Patients receiving 3D BT showed lower rates of Grade 3-4 toxicities compared to those receiving 2D BT. However, the certainty of evidence for all assessed outcomes was considered very low.

BRACHYTHERAPY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer

Mahdieh Dayyani et al.

Summary: This study aimed to compare the biological effective doses (BEDs) to clinical target volume (CTV) and organs at risk (OARs) for cervical cancer patients treated with high-dose-rate (HDR) Iridium-192 (Ir-192) or Cobalt-60 (Co-60) brachytherapy (BT) boost and found that RBE values are the most important cause of discrepancies between the two sources. The study suggests that a dose escalation to similar to 4% is feasible and safe, but further clinical validation is needed.

MEDICAL PHYSICS (2021)

Article Oncology

A comparison between 2D and 3D planning of high-dose-rate vaginal cuff brachytherapy in patients with stage I-II endometrial cancer using cobalt-60

Farnaz Amouzegar Hashemi et al.

Summary: Comparing the results of 2D and 3D planning showed that 3D planning could deliver an appropriate dose to the target while sparing more OARs.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2021)

Article Oncology

Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix a - retrospective study

Anis Bandyopadhyay et al.

Summary: Brachytherapy for cervical cancer has evolved from Point A based planning to dose optimization based on HR-CTV. While guidelines exist for HR-CTV delineation, many centers still rely on CT based planning, which may limit accurate contouring. Studies have shown promising clinical outcomes with CT-based HR-CTV delineation, but more research is needed to fully understand its effectiveness.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2021)

Article Oncology

Estimation and comparison of integral dose to target and organs at risk in three-dimensional computed tomography image-based treatment planning of carcinoma uterine cervix with two high-dose-rate brachytherapy sources: 60Co and 192Ir

Suresh Yadav et al.

Summary: This study compared the effects of 192Ir and 60Co as HDR brachytherapy sources in the treatment of cervical cancer. The results showed that the integral dose to the high-risk clinical target volume and organs at risk was lower with 192Ir radioisotope, indicating better clinical outcomes.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2021)

Article Oncology

Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy

Alexandra Hochreiter et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Article Oncology

Dosimetric comparison of 60Co and 192Ir high dose rate source used in brachytherapy treatment of cervical cancer

Arvind Kumar Shukla et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)

Review Environmental Sciences

Ionizing radiation exposure: hazards, prevention, and biomarker screening

Hongxiang Mu et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2018)

Article Oncology

Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer

Kris Derks et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of Ir-192, Yb-169, and Co-60 high-dose rate brachytherapy sources for skin cancer treatment

Habib Safigholi et al.

MEDICAL PHYSICS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of dose uniformity around high dose rate 192Ir and 60Co stepping sources

Bagher Farhood et al.

RADIOLOGICAL PHYSICS AND TECHNOLOGY (2017)

Article Oncology

Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60)

V. Tormo Ferrero et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2017)

Article Oncology

Iridium-Knife: Another knife in radiation oncology

Natasa Milickovic et al.

BRACHYTHERAPY (2017)

Review Obstetrics & Gynecology

Changing paradigms in the systemic treatment of advanced cervical cancer

Krista S. Pfaendler et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: 192Ir, 60Co and an electronic brachytherapy source

Paul N. Mobit et al.

BRITISH JOURNAL OF RADIOLOGY (2016)

Article Oncology

Study of the dosimetric differences between 192Ir and 60Co sources of high dose rate brachytherapy for breast interstitial implant

Mourougan Sinnatamby et al.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2016)

Editorial Material Oncology

Curative Radiation Therapy for Locally Advanced Cervical Cancer: Brachytherapy Is NOT Optional

Kari Tanderup et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer

Z. K. Zaman et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2014)

Article Oncology

Brachytherapy in cancer cervix: Time to move ahead from point A?

Anurita Srivastava et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Health Care Sciences & Services

Dose optimization in high-dose-rate brachytherapy: A literature review of quantitative models from 1990 to 2010

L. De Boecka et al.

OPERATIONS RESEARCH FOR HEALTH CARE (2014)

Article Oncology

Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States

Kathy Han et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Review Oncology

Comparison of Co-60 and Ir-192 sources in HDR brachytherapy

Stefan Strohmaier et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2011)

Article Chemistry, Inorganic & Nuclear

A comparison of dose distributions of HDR intracavitary brachytherapy using different sources and treatment planning systems

Dong-Wook Park et al.

APPLIED RADIATION AND ISOTOPES (2009)

Article Oncology

External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed

Lisa Helen Barraclough et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy

Juergen Richter et al.

STRAHLENTHERAPIE UND ONKOLOGIE (2008)

Article Oncology

Correlation of traditional point a with anatomic location of uterine artery and ureter in cancer of the uterine cervix

Kung-Liahng Wang et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Technical note:: Dosimetric study of a. new Co-60 source used in brachytherapy

D. Granero et al.

MEDICAL PHYSICS (2007)

Article Oncology

Rectum dose analysis employing a multi-purpose brachytherapy phantom

HyunDo Huh et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Oncology

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:: Clinical feasibility and preliminary results

Johannes C. A. Dimopoulos et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix

A Katz et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)